术前被动静脉压驱动的心功能决定左心室辅助装置结局
该研究回顾了2012至2021年在密歇根大学接受连续流左心室辅助装置(LVAD)的383例患者,以右房压与平均肺动脉压比值乘以总心输出量再经体表面积归一化得到被动心指数(PasCI)。术前PasCI升高与生存率降低(HR 2.27,P<.01)及右心衰竭风险增加(HR 3.46,P=.04)相关;PasCI≥0.5(n=226)预测LVAD死亡(P=.10),该组生存率更差(P=.02)。
要点
- 术前PasCI升高与LVAD术后生存率降低(HR 2.27,P<.01)及右心衰竭风险增加(HR 3.46,P=.04)相关。
- 术前PasCI≥0.5(n=226)预测LVAD死亡(P=.10),该组生存率更差(P=.02)。
- PasCI≥0.5组心衰再入院天数有增多趋势(均值45.09±67.64天 vs 35.13±45.02天,P=.084),胃肠道出血有增加趋势(29.2% vs 20.4%,P=.052)。
核心结论
- 右心输出量可通过升高静脉压来增加,但这会对终末器官功能产生负面影响并增加心衰再入院天数。
- 术前PasCI≥0.5的患者LVAD术后生存率更差且右心衰竭增加。
- 单独使用PasCI指标或将其纳入预测模型可能改善对合并右心功能障碍的LVAD候选者的管理。
研究设计与样本
- 回顾性综述,纳入2012年至2021年在密歇根大学接受连续流LVAD的383例患者。
- 术前静脉压驱动的心输出量通过右房压除以平均肺动脉压再乘以总心输出量计算,经体表面积归一化得到被动心指数(PasCI)。
- 采用约登J统计量确定预测2年内LVAD死亡的PasCI阈值。
主要发现
- 术前PasCI升高与生存率降低相关(HR 2.27;P<.01),并与右心衰竭风险增加相关(HR 3.46;P=.04)。
- 约登分析显示术前PasCI≥0.5(n=226)预测LVAD死亡(P=.10)。
- PasCI≥0.5组生存率更差(P=.02),心衰再入院天数有增多趋势(均值45.09±67.64天 vs 35.13±45.02天;P=.084),胃肠道出血有增加趋势(29.2% vs 20.4%;P=.052)。
- 在97例因心衰再入院的患者中,术前PasCI≥0.5者更可能发生超过1次再入院(P=.05)。
关键数值与推荐
- PasCI阈值≥0.5(n=226)用于预测LVAD死亡(P=.10)。
- 术前PasCI升高与生存率降低相关(HR 2.27;P<.01)。
- 术前PasCI升高与右心衰竭风险增加相关(HR 3.46;P=.04)。
临床怎么用
- 作者认为单独使用PasCI指标或将其纳入预测模型可能改善对合并右心功能障碍的LVAD候选者的管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Right heart output in heart failure can be compensated through increasing systemic venous pressure. We determined whether the magnitude of this "passive cardiac output" can predict LVAD outcomes. METHODS: This was a retrospective review of 383 patients who received a continuous-flow LVAD at the University of Michigan between 2012 and 2021. Pre-LVAD cardiac output driven by venous pressure was determined by dividing right atrial pressure by mean pulmonary artery pressure, multiplied by total cardiac output. Normalization to body surface area led to the passive cardiac index (PasCI). The Youden J statistic was used to identify the PasCI threshold, which predicted LVAD death by 2 years. RESULTS: Increased preoperative PasCI was associated with reduced survival (hazard ratio [HR], 2.27; P < .01), and increased risk of right ventricular failure (RVF) (HR, 3.46; P = .04). Youden analysis showed that a preoperative PasCI ≥0.5 (n = 226) predicted LVAD death (P = .10). Patients with PasCI ≥0.5 had poorer survival (P = .02), with a trend toward more heart failure readmission days (mean, 45.09 ± 67.64 vs 35.13 ± 45.02 days; P = .084) and increased gastrointestinal bleeding (29.2% vs 20.4%; P = .052). Additionally, of the 97 patients who experienced readmissions for heart failure, those with pre-LVAD implantation PasCI ≥0.5 were more likely to have more than 1 readmission (P = .05). CONCLUSIONS: Although right heart output can be augmented by raising venous pressure, this negatively impacts end-organ function and increases heart failure readmission days. Patients with a pre-LVAD PasCI ≥0.5 have worse post-LVAD survival and increased RVF. Using the PasCI metric in isolation or incorporated into a predictive model may improve the management of LVAD candidates with RV dysfunction.
引用
- Tang PC, Millar J, Noly PE, et al. Preoperative passive venous pressure-driven cardiac function determines left ventricular assist device outcomes. J Thorac Cardiovasc Surg. 2023. PMID: 37495169. doi:10.1016/j.jtcvs.2023.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。